11/30/2018

BOT meets face-to-face and visits KCDC & LG Chem’s vaccine plant

Members of the IVI Board of Trustees On Nov. 19, 2018, IVI’s Board of Trustees convened at IVI headquarters in Seoul for their second face-to-face meeting of the year. This was followed by a visit to the Korea Center for Disease Control (KCDC) on Nov. […]
12/12/2018

Nature Communications study addresses MDR typhoid

New study in Nature Communications reveals high burden of multi-drug resistant (MDR) typhoid fever in sub-Saharan Africa associated with two predominant genotypes – IVI epidemiologist Se Eun Park and collaborating scientists report data from Typhoid Fever Surveillance in Africa (TSAP) program and other sources   […]
01/09/2019

Henry Lau joins IVI as Goodwill Ambassador

– Singer-songwriter, Henry to team up with the International Vaccine Institute (IVI), founded by the United Nations Development Programme to develop and deliver new vaccines for global health – IVI Director General Dr. Jerome Kim: “IVI is privileged to have Henry on board, and grateful […]
01/09/2019

IVI Director General addresses ‘neglected diseases’ in STAT News

We are pleased to share IVI Director General Dr. Jerome Kim’s First Opinion Editorial: “‘Neglected diseases’ are anything but neglected by the billion-plus people living with them,” which was published recently in STAT News, a major news portal in health and science. Read the article as […]